AU3665899A - Methods for transducing fusion molecules - Google Patents

Methods for transducing fusion molecules Download PDF

Info

Publication number
AU3665899A
AU3665899A AU36658/99A AU3665899A AU3665899A AU 3665899 A AU3665899 A AU 3665899A AU 36658/99 A AU36658/99 A AU 36658/99A AU 3665899 A AU3665899 A AU 3665899A AU 3665899 A AU3665899 A AU 3665899A
Authority
AU
Australia
Prior art keywords
fusion
protein
misfolded
molecule
fusion protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU36658/99A
Other languages
English (en)
Inventor
Steven F. Dowdy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Washington University in St Louis WUSTL
Original Assignee
University of Washington
Washington University in St Louis WUSTL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Washington, Washington University in St Louis WUSTL filed Critical University of Washington
Publication of AU3665899A publication Critical patent/AU3665899A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1136—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by reversible modification of the secondary, tertiary or quarternary structure, e.g. using denaturating or stabilising agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
    • C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU36658/99A 1998-04-28 1999-04-27 Methods for transducing fusion molecules Abandoned AU3665899A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8338098P 1998-04-28 1998-04-28
US60083380 1998-04-28
PCT/US1999/009028 WO1999055899A1 (fr) 1998-04-28 1999-04-27 Methodes de transduction de molecules de fusion

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2003244303A Division AU2003244303A1 (en) 1998-04-28 2003-09-02 Methods for transducing fusion molecules

Publications (1)

Publication Number Publication Date
AU3665899A true AU3665899A (en) 1999-11-16

Family

ID=22177935

Family Applications (2)

Application Number Title Priority Date Filing Date
AU36658/99A Abandoned AU3665899A (en) 1998-04-28 1999-04-27 Methods for transducing fusion molecules
AU2003244303A Abandoned AU2003244303A1 (en) 1998-04-28 2003-09-02 Methods for transducing fusion molecules

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2003244303A Abandoned AU2003244303A1 (en) 1998-04-28 2003-09-02 Methods for transducing fusion molecules

Country Status (5)

Country Link
EP (1) EP1073763A4 (fr)
JP (1) JP2002512808A (fr)
AU (2) AU3665899A (fr)
CA (1) CA2330560A1 (fr)
WO (1) WO1999055899A1 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1818299A (en) * 1997-12-10 1999-06-28 Washington University Anti-pathogen system and methods of use thereof
AU2172800A (en) * 1998-12-10 2000-06-26 Washington University Protein transduction system and methods of use thereof
JP2002541786A (ja) * 1999-04-12 2002-12-10 モデックス テラピューティク ソシエテ アノニム 遺伝子治療における使用のための一過性不死化細胞
US6358739B1 (en) * 1999-04-12 2002-03-19 Modex Therapeutiques, S.A. Transiently immortalized cells
US6881825B1 (en) 1999-09-01 2005-04-19 University Of Pittsburgh Of The Commonwealth System Of Higher Education Identication of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, DNA and virues
CA2396149A1 (fr) * 2000-01-07 2001-07-12 Artemis Pharmaceuticals Gmbh Transduction de recombinases pour ciblage genetique inductible
US7037889B2 (en) 2000-09-13 2006-05-02 Praecis Pharmaceuticals Inc. Pharmaceutical compositions for sustained drug delivery
JP2002331695A (ja) * 2001-05-11 2002-11-19 Fuji Xerox Co Ltd インクジェットプリンタの印字システムおよびインクジェット記録方法とインクジェットプリンタ
US8022172B2 (en) 2001-08-28 2011-09-20 Allergan, Inc. Luminescence resonance energy transfer (LRET) assays for clostridial toxin activity
US7332567B2 (en) 2001-08-28 2008-02-19 Allergan, Inc. Fret protease assays for clostridial toxins
US7374896B2 (en) 2001-08-28 2008-05-20 Allergan, Inc. GFP-SNAP25 fluorescence release assay for botulinum neurotoxin protease activity
DE10212867B4 (de) * 2002-03-22 2005-07-21 Hans Prof. Dr. Wolf Verwendung Harnstoff-adjuvierter Polypeptide zur Diagnose, Prophylaxe und Therapie
US7183066B2 (en) 2002-09-27 2007-02-27 Allergan, Inc. Cell-based fluorescence resonance energy transfer (FRET) assays for clostridial toxins
US7399607B2 (en) 2004-09-22 2008-07-15 Allergan, Inc. Fluorescence polarization assays for determining clostridial toxin activity
ES2351942T3 (es) 2005-04-05 2011-02-14 Allergan Inc Analisis de la actividad de una toxina clostridial.
CN101374860A (zh) * 2005-12-23 2009-02-25 技术转让合伙人公司 用作神经递质分泌抑制剂和肌肉松弛诱导物的合成肽
EP2239569A1 (fr) 2009-04-09 2010-10-13 Lophius Biosciences GmbH Procédé de transfert de polypeptide dans des cellules
US20130079382A1 (en) 2009-10-12 2013-03-28 Larry J. Smith Methods and Compositions for Modulating Gene Expression Using Oligonucleotide Based Drugs Administered in vivo or in vitro
EP2844261B1 (fr) 2012-05-02 2018-10-17 Sirna Therapeutics, Inc. Compositions de petit acide nucléique interférent (sina)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4999422A (en) * 1988-04-15 1991-03-12 Biogen, N.V. Continuous method of refolding proteins
US5747641A (en) * 1989-12-21 1998-05-05 Biogen Inc Tat-derived transport polypeptide conjugates

Also Published As

Publication number Publication date
EP1073763A4 (fr) 2002-08-07
WO1999055899A1 (fr) 1999-11-04
WO1999055899A9 (fr) 1999-12-16
CA2330560A1 (fr) 1999-11-04
AU2003244303A1 (en) 2003-09-25
JP2002512808A (ja) 2002-05-08
EP1073763A1 (fr) 2001-02-07

Similar Documents

Publication Publication Date Title
AU3665899A (en) Methods for transducing fusion molecules
Becker-Hapak et al. TAT-mediated protein transduction into mammalian cells
Ayers et al. Introduction of unnatural amino acids into proteins using expressed protein ligation
JP4188909B2 (ja) 細胞質残留性細胞膜透過ペプチド及びこれの用途｛ＣｙｔｏｐｌａｓｍｉｃＴｒａｎｓｄｕｃｔｉｏｎＰｅｐｔｉｄｅｓａｎｄＵｓｅｓｔｈｅｒｅｏｆ｝
Moroianu et al. The binding site of karyopherin alpha for karyopherin beta overlaps with a nuclear localization sequence.
EP1991560B1 (fr) Peptide présentant une activité de pénétration de membrane cellulaire
US8192953B2 (en) Trimerising module
Chou et al. Hepatitis delta antigen mediates the nuclear import of hepatitis delta virus RNA
JP2019533999A (ja) 直交（ｏｒｔｈｏｇｏｎａｌ）用途の古細菌ピロリジルｔＲＮＡ合成酵素
Vocero-Akbani et al. Protein transduction: delivery of Tat-GTPase fusion proteins into mammalian cells
US20030134352A1 (en) Facilitating protein folding and solubility by use of peptide extensions
JP2022549057A (ja) 分子の細胞内送達のための複合体
US6395875B1 (en) Recombinant soluble adenovirus receptor
Becker‐Hapak et al. Protein Transduction: Generation of Full‐Length Transducible Proteins Using the TAT System
JPH01180900A (ja) 細胞接着活性ポリペプチド
KR100843634B1 (ko) 세포막투과 전달 펩타이드 및 이를 포함하는 생물제제
JPH03259084A (ja) トロンビン結合性物質の製造法
WO2002085305A2 (fr) Compositions et methodes pouvant induire la mort de cellules cancereuses
EP2386570B1 (fr) Protéine de fusion de mélusine recombinante en tant qu'agent pharmacologique pour le traitement des pathologies cardiaques et compositions associées
JP4721564B2 (ja) ヒト細胞膜結合蛋白
Manoharan et al. High-level production and purification of biologically active proteins from bacterial and mammalian cells using the tandem pGFLEX expression system
Rothe et al. Expression and purification of ZEBRA fusion proteins and applications for the delivery of macromolecules into mammalian cells
WO2011079431A1 (fr) Protéine de fusion ayant une activité inhibitrice de télomérase, son procédé de préparation et utilisation
KR20200113764A (ko) 폴리글루타메이트-TAT-Cre 융합 단백질의 제조방법
Yan et al. Study on the penetrability of PEP-1-P27mt for cell membranes in Vitro

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted